- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-Risk Prostate Cancer in United Kingdom
Total 3585 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Belfast Health and Social Care TrustActive, not recruiting
-
Imperial College LondonWellcome TrustRecruitingProstate Cancer | Metastatic Prostate CancerUnited Kingdom
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
University College, LondonUniversity College London HospitalsRecruitingProstate CancerUnited Kingdom
-
Massachusetts General HospitalBayerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer Metastatic to BoneUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
University College, LondonActive, not recruiting
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Case Comprehensive Cancer CenterCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Astellas Pharma Inc; Medivation, Inc.Active, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Virginia Commonwealth UniversityCompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
University Hospital Plymouth NHS TrustCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
Hull University Teaching Hospitals NHS TrustUniversity of HullCompleted
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Weill Medical College of Cornell UniversityProgenics Pharmaceuticals, Inc.; Viewray Inc.RecruitingProstate CancerUnited States, United Kingdom
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Hormone-Resistant Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.SuspendedProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer... and other conditionsUnited States
-
University of OxfordNational Institute for Health Research, United KingdomEnrolling by invitationBreast Cancer | Risk ReductionUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
Imperial College LondonWithdrawn
-
University of ChicagoNational Cancer Institute (NCI)CompletedStage II Prostate Carcinoma | Stage I Prostate CancerUnited States
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingCancer Survivor | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Brander Beacons Cancer ResearchActive, not recruitingCancer Survivor | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingProstate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, United Kingdom
-
University of CincinnatiUnknownCastration-resistant Prostate Cancer | Cancer of the ProstateUnited States
-
Exact ImagingCompletedProstate Cancer | Prostatic Neoplasm | Cancer of the PROSTATEUnited States
-
University of California, DavisSanofiTerminatedHormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
BayerCompletedNeoplasm Metastasis | Prostate CancerSweden, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v7 | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7 | Stage II Prostate Cancer AJCC v7United States
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Pharmavite LLC; Seafood Industry Research FundActive, not recruitingStage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Rashmi Verma, MDNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage I Prostate Cancer AJCC V7 | Stage IIA Prostate Cancer AJCC v7United States